Quick Answer
Vitamin K2 Bone Density Systematic Review has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Currently, large-scale direct comparative statistics are still insufficient, but existing evidence supports that Asian dietary patterns are more beneficial to skeletal health.
Key Takeaways
- 01Currently, large-scale direct comparative statistics are still insufficient, but existing evidence supports that Asian dietary patterns are more beneficial to skeletal health. [Zhang Tianzhu (2026)]
- 02Despite substantial progress, the field still faces several bottlenecks, including unclear strain-specific and compound-specific mechanisms, insufficient large-scale clinical evidence, low bioavailability of phytochemicals, and lack of standardized intervention regimens. [Zhang Tianzhu (2026)]
- 03By integrating mechanistic insights, preclinical evidence, clinical advances, and translational prospects, this review aims to enrich the current understanding of the gut–bone axis and provide a theoretical foundation and practical guidance for subsequent research and clinical development of plant-based therapies against osteoporosis and other metabolic bone diseases. [Zhang Tianzhu (2026)]
- 041 2 The gut–bone axis refers to the functional connection between the gut and the skeletal system, established through a complex bidirectional communication network. [Zhang Tianzhu (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin K2 Bone Density Systematic Review. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Currently, large-scale direct comparative statistics are still insufficient, but existing evidence supports that Asian dietary patterns are more beneficial to skeletal health. [Zhang Tianzhu (2026); evidence level 3]
- Despite substantial progress, the field still faces several bottlenecks, including unclear strain-specific and compound-specific mechanisms, insufficient large-scale clinical evidence, low bioavailability of phytochemicals, and lack of standardized intervention regimens. [Zhang Tianzhu (2026); evidence level 3]
- By integrating mechanistic insights, preclinical evidence, clinical advances, and translational prospects, this review aims to enrich the current understanding of the gut–bone axis and provide a theoretical foundation and practical guidance for subsequent research and clinical development of plant-based therapies against osteoporosis and other metabolic bone diseases. [Zhang Tianzhu (2026); evidence level 3]
- 1 2 The gut–bone axis refers to the functional connection between the gut and the skeletal system, established through a complex bidirectional communication network. [Zhang Tianzhu (2026); evidence level 3]
- In OVX mice, MK-4 treatment significantly increased alkaline phosphatase activity and bone volume, improved bone mineral density (BMD), and reduced undercarboxylated osteocalcin (ucOC) []. [Jecan Alexandru (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources